A series of novel 1-piperidinesulfonylurea compounds derived from a nitrogen-containing monocarboxylic acid have been prepared by reacting an appropriate sulfamide with an organic isocyanate or a trisubstituted urea equivalent thereof. The sulfamylureas so obtained are useful in therapy as oral hypoglycemic agents. Typical members include those compounds derived from 2-methoxynicotinic acid, of which 1-(bicyclo[2.2.1]hept-5-en-2-yl-endo-methyl)-3-4-[2-(2-methoxynicotinamid o)ethyl]-1-piperidinesulfonyl}-urea is a most preferred embodiment.
一系列新型1-
哌啶磺酰
脲化合物,是通过将适当的磺酰胺与有机
异氰酸酯或三取代
脲等效物反应而制备的,该磺酰
脲可作为口服降血糖药物在治疗中有用。典型成员包括从
2-甲氧基烟酸酸衍生的化合物,其中1-(双环[2.2.1]庚-5-烯-2-基内-甲基)-3-4-[2-(2-甲氧基烟酰胺)乙基]-1-
哌啶磺酰}-
脲是最优选的实施形式。